The neuropathic diabetic foot ulcer microbiome is associated with clinical factors

Diabetes

Volumn 62, Issue 3, 2013, Pages 923-930

  Gardner, Sue E ^a   Hillis, Stephen L ^b   Heilmann, Kris ^b   Segre, Julia A ^c   Grice, Elizabeth A ^d  

^a UNIVERSITY OF IOWA COLLEGE OF NURSING   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ADULT; ANAEROBIC BACTERIUM; ARTICLE; BACTERIAL GENE; DIABETIC FOOT; FEMALE; GLYCEMIC CONTROL; HIGH THROUGHPUT SEQUENCING; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; MICROBIOME; NEUROPATHY; PRIORITY JOURNAL; PROTEOBACTERIA; STAPHYLOCOCCUS;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETIC FOOT; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROTEOBACTERIA; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; UNITED STATES; WOUND HEALING;

EID: 84874444175     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0771     Document Type: Article

References (49)

1. Maldonado M, Hampe CS, Gaur LK, et al. Ketosis-prone diabetes: Dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 2003;88:5090-5098
2. Kitabchi AE. Ketosis-prone diabetes-A new subgroup of patients with atypical type 1 and type 2 diabetes? J Clin Endocrinol Metab 2003;88:5087-5089
3. Mauvais-Jarvis F, Sobngwi E, Porcher R, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: Clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 2004;53:645-653
4. Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: Ketosis-prone type 2 diabetes mellitus. Ann Intern Med 2006;144:350-357
5. Balasubramanyam A, Nalini R, Hampe CS, Maldonado M. Syndromes of ketosis-prone diabetes mellitus. Endocr Rev 2008;29:292-302
6. Balasubramanyam A, Garza G, Rodriguez L, et al. Accuracy and predictive value of classification schemes for ketosis-prone diabetes. Diabetes Care 2006;29:2575-2579
7. Banerji MA, Dham S. A comparison of classification schemes for ketosisprone diabetes. Nat Clin Pract Endocrinol Metab 2007;3:506-507
8. Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS. Diabetic ketoacidosis in obese African-Americans. Diabetes 1995;44:790-795
9. Maldonado MR, Otiniano ME, Cheema F, Rodriguez L, Balasubramanyam A. Factors associated with insulin discontinuation in subjects with ketosisprone diabetes but preserved beta-cell function. Diabet Med 2005;22:1744-1750
10. Nalini R, Ozer K, Maldonado M, et al. Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of "A-b+" ketosis-prone diabetes based on long-term b-cell function, human leukocyte antigen class II alleles, and sex predilection. Metabolism 2010;59: 1448-1455
11. Nalini R, Gaur LK, Maldonado M, et al. HLA class II alleles specify phenotypes of ketosis-prone diabetes. Diabetes Care 2008;31:1195-1200
12. Rasouli N, Elbein SC. Improved glycemic control in subjects with atypical diabetes results from restored insulin secretion, but not improved insulin sensitivity. J Clin Endocrinol Metab 2004;89:6331-6335
13. Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009;9:311-326
14. Chen H, Sullivan G, Quon MJ. Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 2005;54:1914-1925
15. Ho DE, Imai K, King G, Stuart EA. MatchIt: Nonparametric preprocessing for parametric causal inference [Internet], 2011. Vol. 42, Issue 8. Journal of Statistical Software. Available from http://www.jstatsoft.org/v42/i08
16. Duarte NL, Wang XL, Wilcken DE. Effects of anticoagulant and time of plasma separation on measurement of homocysteine. Clin Chem 2002;48: 665-668
17. Hachey DL, Patterson BW, Reeds PJ, Elsas LJ. Isotopic determination of organic keto acid pentafluorobenzyl esters in biological fluids by negative chemical ionization gas chromatography/mass spectrometry. Anal Chem 1991;63:919-923
18. Mohammad MA, Sunehag AL, Rodriguez LA, Haymond MW. Galactose promotes fat mobilization in obese lactating and nonlactating women. Am J Clin Nutr 2011;93:374-381
19. Kao CC, Bandi V, Guntupalli KK, Wu M, Castillo L, Jahoor F. Arginine, citrulline and nitric oxide metabolism in sepsis. Clin Sci (Lond) 2009;117: 23-30
20. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983;55:628-634
21. Sidossis LS, Coggan AR, Gastaldelli A, Wolfe RR. A new correction factor for use in tracer estimations of plasma fatty acid oxidation. Am J Physiol 1995;269:E649-E656
22. Wolfe RR, Jahoor F. Recovery of labeled CO2 during the infusion of C-1-vs C-2-labeled acetate: Implications for tracer studies of substrate oxidation. Am J Clin Nutr 1990;51:248-252
23. Schaefer A, Piquard F, Haberey P. Plasma amino-acids analysis: Effects of delayed samples preparation and of storage. Clin Chim Acta 1987;164:163-169
24. Reichert MC. Innovations in sterilization technology for instrument processing. Med Instrum 1983;17:89-90
25. Ukida M, Schäfer K, Bode JC. Effect of storage at 20° C on the concentration of amino acids in plasma. J Clin Chem Clin Biochem 1981;19:1193-1195
26. Scriver CR, Lamm P, Clow CL. Plasma amino acids: Screening, quantitation, and interpretation. Am J Clin Nutr 1971;24:876-890
27. Felig P, Marliss E, Ohman JL, Cahill CF Jr. Plasma amino acid levels in diabetic ketoacidosis. Diabetes 1970;19:727-728
28. Wahren J, Felig P, Cerasi E, Luft R. Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus. J Clin Invest 1972;51:1870-1878
29. Carlsten A, Hallgren B, Jagenburg R, Svanborg A, Werkö L. Amino acids and free fatty acids in plasma in diabetes. I. The effect of insulin on the arterial levels. Acta Med Scand 1966;179:361-370
30. Nair KS, Garrow JS, Ford C, Mahler RF, Halliday D. Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 1983;25:400-403
31. Stefan N, Wahl HG, Fritsche A, Häring H, Stumvoll M. Effect of the pattern of elevated free fatty acids on insulin sensitivity and insulin secretion in healthy humans. Horm Metab Res 2001;33:432-438
32. Hutson SM. The case for regulating indispensable amino acid metabolism: The branched-chain alpha-keto acid dehydrogenase kinase-knockout mouse. Biochem J 2006;400:e1-e3
33. Darmaun D, Déchelotte P. Role of leucine as a precursor of glutamine alpha-amino nitrogen in vivo in humans. Am J Physiol 1991;260: E326-E329
34. Darmaun D, Matthews DE, Bier DM. Physiological hypercortisolemia increases proteolysis, glutamine, and alanine production. Am J Physiol 1988; 255:E366-E373
35. Wagenmakers AJ, Coakley JH, Edwards RH. Metabolism of branchedchain amino acids and ammonia during exercise: Clues from McArdle's disease. Int J Sports Med 1990;11(Suppl. 2):S101-S113
36. Umpierrez GE, Smiley D, Robalino G, Peng L, Gosmanov AR, Kitabchi AE. Lack of lipotoxicity effect on beta-cell dysfunction in ketosis-prone type 2 diabetes. Diabetes Care 2010;33:626-631
37. Oresic M, Simell S, Sysi-Aho M, et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med 2008;205:2975-2984
38. Hrebícek J, Janout V, Malincíková J, Horáková D, Cízek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002;87:144-147
39. Haas BJ, Gevers D, Earl AM, et al Human Microbiome Consortium. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res 2011;21:494-504
40. Schloss PD, Westcott SL. Assessing and improving methods used in operational taxonomic unit-based approaches for 16S rRNA gene sequence analysis. Appl Environ Microbiol 2011;77:3219-3226
41. Cole JR, Chai B, Farris RJ, et al. The Ribosomal Database Project (RDP-II): Introducing myRDP space and quality controlled public data. Nucleic Acids Res 2007;35(Database issue):D169-D172
42. Matsen FA, Kodner RB, Armbrust EV. pplacer: Linear time maximumlikelihood and Bayesian phylogenetic placement of sequences onto a fixed reference tree. BMC Bioinformatics 2010;11:538
43. Grice EA, Kong HH, Renaud G, et al NISC Comparative Sequencing Program. A diversity profile of the human skin microbiota. Genome Res 2008; 18:1043-1050
44. Rousseeuw PJ. Silhouettes: A graphical aid to the interpretation and validation of cluster-analysis. J Comput Appl Math 1987;20:53-65
45. Fleiss JL. Statistical methods for rates and proportions. New York, Wiley, 1981
46. Anderson MJ. A new method for non-parametric multivariate analysis of variance. Austral Ecol 2001;26:32-46
47. Pathare NA, Bal A, Talvalkar GV, Antani DU. Diabetic foot infections: A study of microorganisms associated with the different Wagner grades. Indian J Pathol Microbiol 1998;41:437-441
48. Han A, Zenilman JM, Melendez JH, et al. The importance of a multifaceted approach to characterizing the microbial flora of chronic wounds. Wound Repair Regen 2011;19:532-541
49. Heggers JP, Robson, MC. Variations on a theme. In Quantitative bacteriology: Its role in the armamentarium of the surgeon Heggers JP, Robson MD, Eds. Boca Raton, CRC Press, 1991, p. 15-23